Podcasts Other S&C Critical Insights Industry and Regulatory Considerations for Healthcare Company Boards

Industry and Regulatory Considerations for Healthcare Company Boards

Published: April 5, 2021, 8:45 p.m.

b'In this episode of S&C\\u2019s\\xa0Critical Insights\\xa0podcast, Frank Aquila, Global Head of M&A, and Melissa Sawyer, co-head of our Corporate Governance & Activism practice, examine industry and regulatory trends that will shape boardroom discussions at healthcare companies. Frank and Melissa discuss how regulatory activity in other sectors might inform the healthcare industry\\u2019s interactions with regulators. They also explore what boards should be thinking about as companies prepare to announce large healthcare acquisitions.\\n\\xa0\\nFor more information, visit us at\\xa0Sullcrom.com.'